Compliance of metabolic monitoring at rehabilitation facilities

Abstract

Objectives:

To examine compliance with routine metabolic monitoring at four rehabilitation facilities within the Metro South Addiction and Mental Health Services in Queensland.

Methods:

A retrospective chart audit was undertaken on 63 residents of rehabilitation facilities with electronic health records from 1 October 2014 to 30 March 2015.

Results:

Evidence of any metabolic monitoring was recorded for 87% of residents. Compliance rates differed for monitoring waist circumference (97%), blood pressure (97%), high-density lipoprotein (79%), triglycerides (81%) and plasma glucose (83%). Evidence of communication with residents and primary healthcare providers were each found in 41% of the sample.

Conclusions:

In current clinical practice, metabolic monitoring is high for residents of rehabilitation facilities in Queensland with serious mental illness. However, many residents do not receive adequate communication regarding their results and, disturbingly, results are not forwarded to their primary healthcare providers. This can result in people not receiving treatment for modifiable factors of metabolic syndrome.

Keywords

metabolic syndrome monitoring severe mental illness physical health mental health service

Get full access to this article

View all access options for this article.

References

Lawrence

Hancock

Kisely

The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013; 346: f2539.

Holt

Abdelrahman

Hirsch

et al . The prevalence of undiagnosed metabolic abnormalities in people with serious mental illnesses. J Psychopharmacol 2010; 24: 867–873.

Alberti

Zimmet

Shaw

Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabetic Med 2006; 23: 469–480.

Zhang

Mak

et al . Metabolic syndrome in psychiatry: advances in understanding and management. B J Psych Advances 2014; 20: 101–112.

Lambert

Newcomer

JW.

Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Aust 2009; 190: S39–42.

O’Connor

Hunt

O’Hara-Aarons

et al . The Sydney Mental Health Client Mortality Audit: what does it tell us and what are we to do? Australas Psychiatry 2014; 22: 154–159.

Queensland Government Department of Health. Guideline: The use of psychotropic medication for people with schizoprenia, Document number # QH-GDL-430: 2016, https://www.health.qld.gov.au/__data/assets/pdf_file/0020/365051/qh-gdl-430.pdf (accessed 2016).

Tso

Kumar

Jayasooriya

et al . Metabolic monitoring and management among clozapine users. Australas Psychiatry 2017; 25: 48–52.

Happell

Platania-Phung

Gaskin

et al . Use of an electronic metabolic monitoring form in a mental health service – a retrospective file audit. BMC Psychiatry 2016; 16: 109.

10.

Tirupati

Chua

Obesity and metabolic syndrome in a psychiatric rehabilitation service. Aust N Z J Psychiatry 2007; 41: 606–610.

11.

World Health Organization. ICD-10. Classifications of mental and behavioural disorder: clinical descriptions and diagnostic guidelines. Geneva: World Health Organisation, 1992.

12.

De Hert

Vamcampfort

Correll

et al . Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry 2011; 199: 99–105.

13.

Mitchell

Delaffon

Vancampfort

et al . Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012; 42: 125–147.

14.

Maas

AHEM

Appelman

YEA

. Gender differences in coronary heart disease. Neth Heart J 2010; 18: 598–602.

15.

Galletly

Castle

Dark

et al . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016; 50: 410–472.